Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Infusion of Anesthetics Controls Pain Following Lung Surgery

By HospiMedica International staff writers
Posted on 25 Nov 2010
A continuous infusion of local anesthetic just over the intercostal nerve substantially reduces pain and helps patients return to normal faster after thoracic surgery, claims a new study.

Researchers at the Washington Institute of Thoracic and Cardiovascular Surgery (Washington, DC, USA) reviewed the records of 300 thoracic surgery patients given subpleural infusions of 0.25% bupivicaine, at a rate of 2 cc per hour for 10 days. More...
The infusion procedure involved two 12.7-cm catheters placed in a sub-pleural tunnel created by the surgeon, covering intercostal spaces two through eight. The researchers assessed postoperative pain using a 0-10 point Likert pain scale, comparing the results with a historical control group.

The results showed that pain rankings in the infusion group averaged 5 on post-op day one, 3 on day 14, and 1 on day 30, compared to 7.7, 6.8, and 4, respectively, in the control group. The median length of hospital stay in the infusion group was 4 days, not substantially different from the 5-6 day stay in the control group. However, return to normal function was substantially reduced, as was narcotic use for pain control. The study was presented at the annual international scientific assembly of the American College of Chest Physicians (ACCP), held during November 2010 in Vancouver (Canada).

"Usually systemic narcotics and epidurals are used to control pain after thoracic surgery. The problem is, epidurals are cumbersome, they wear off, and patients have to be in the hospital while they're being used. And narcotics have so many side effects,” said lead author and study presenter Barbara Tempesta, R.N., M.S. "The surgeons saw such a difference with the continuous infusions that they didn't want to do a randomized study.”

Significantly, the researchers found that the incidence of post-thoracotomy pain syndrome over a follow-up period of about 4 years was less than 3%; historically, however, about half of all patients undergoing thoracic surgery end up with chronic pain, and about 30% of patients might still experience pain 4-5 years later.

Related Links:
Washington Institute of Thoracic and Cardiovascular Surgery


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Infant Incubator
OKM 801
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.